These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8710917)

  • 21. A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis.
    Kanalas JJ; Makker SP
    J Immunol; 1988 Dec; 141(12):4152-7. PubMed ID: 3264306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis.
    Tramontano A; Makker SP
    J Immunol; 2004 Feb; 172(4):2367-73. PubMed ID: 14764706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of cDNAs encoding immunogenic regions of gp330, the autoantigen involved in Heymann nephritis.
    Luca ME; De Geus B; Sahali D; Bruijn JA; Verroust P; De Heer E
    Clin Exp Immunol; 1996 May; 104(2):312-7. PubMed ID: 8625526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
    Huang J; Makker SP
    Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.
    Farquhar MG
    Am J Pathol; 1996 May; 148(5):1331-7. PubMed ID: 8623903
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro.
    Niemeier A; Willnow T; Dieplinger H; Jacobsen C; Meyer N; Hilpert J; Beisiegel U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):552-61. PubMed ID: 10073957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis.
    Marinò M; Chiovato L; Friedlander JA; Latrofa F; Pinchera A; McCluskey RT
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2468-74. PubMed ID: 10404822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV; Makker SP
    J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
    Kerjaschki D; Neale TJ
    J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties.
    Hjälm G; Murray E; Crumley G; Harazim W; Lundgren S; Onyango I; Ek B; Larsson M; Juhlin C; Hellman P; Davis H; Akerström G; Rask L; Morse B
    Eur J Biochem; 1996 Jul; 239(1):132-7. PubMed ID: 8706697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gp330 and RAP: the Heymann nephritis antigenic complex.
    Farquhar MG; Kerjaschki D; Lundstrom M; Orlando RA
    Ann N Y Acad Sci; 1994 Sep; 737():96-113. PubMed ID: 7944157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes.
    Czekay RP; Orlando RA; Woodward L; Lundstrom M; Farquhar MG
    Mol Biol Cell; 1997 Mar; 8(3):517-32. PubMed ID: 9188102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nested sets of protein fragments and their use in epitope mapping: characterization of the epitope for the S4D5 monoclonal antibody binding to receptor associated protein.
    Ellgaard L; Holtet TL; Moestrup SK; Etzerodt M; Thøgersen HC
    J Immunol Methods; 1995 Mar; 180(1):53-61. PubMed ID: 7534803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a heparin-binding region of rat thyroglobulin involved in megalin binding.
    Marinò M; Friedlander JA; McCluskey RT; Andrews D
    J Biol Chem; 1999 Oct; 274(43):30377-86. PubMed ID: 10521414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.
    Specht Grijp-Glandorf RJ; De Heer E; Dekker-Nooren CC; Daha MR; Van Es LA
    Immunology; 1990 Jul; 70(3):290-5. PubMed ID: 1696240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.